ORION CORPORATION

Orion Corporation is a globally operating Finnish company developing pharmaceuticals and diagnostic tests โ a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhalerยฎ pulmonary drugs.
ORION CORPORATION
Industry:
Pharmaceutical
Founded:
1970-01-01
Address:
Espoo, Southern Finland, Finland
Country:
Finland
Website Url:
http://www.orion.fi
Total Employee:
5001+
Status:
Active
Contact:
+358 10 4261
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon Apache Global Site Tag Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-06-15 | VMD nv | VMD nv acquired by Orion Corporation | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2012-02-01 | Visionplus | Orion Corporation investment in Venture Round - Visionplus | N/A |
Official Site Inspections
http://www.orion.fi Semrush global rank: 1.16 M Semrush visits lastest month: 27.18 K
- Host name: 217.114.94.2
- IP address: 217.114.94.2
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm

More informations about "Orion Corporation"
Orion Corporation (Finnish company) - Wikipedia
Orion Corporation (Finnish: Orion Oyj), founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland. See details»
Orion Pharma - Building well-being
Stock exchange releases. 3/11/2025 Orion Group Financial Statement documents 2024 and Remuneration Report published; 3/10/2025 Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025; 2/25/2025 Orion Corporation: โฆSee details»
About Orion
Orion strategy 2024โ2028: The road is open for growth through well-being. By the 2030s, Orion will be a truly global, innovative, and patient-focused pharmaceutical company that serves โฆSee details»
Orion Pharma โ hyvinvointia rakentamassa
Nov 27, 2024 Orion on suomalainen yli satavuotias lääkeyhtiö - hyvinvoinnin rakentaja, joka toimii maailmanlaajuisesti. Kehitämme, valmistamme ja markkinoimme ihmis- ja eläinlääkkeitä โฆSee details»
About Orion - production.orion.fi
Orion is a globally operating Finnish pharmaceutical company โ a builder of well-being.See details»
Orion (yritys) โ Wikipedia
Orion Oyj on suomalainen lääketeollisuusyhtiö, jonka osake noteerataan Helsingin pörssissä. Orionilla on tuotanto- ja tutkimustoimintaa Espoon pääkonttorin lisäksi Kuopiossa , Oulussa , โฆSee details»
Sijoittajat - production.orion.fi
Lehdistötiedotteet. 21.3.2025 Lääketeollisuus luovutti hallitukselle arvolupauksen: miljarditason investoinnit vuoteen 2030 mennessä; 10.3.2025 Orion avaa uuden biologisten lääkkeiden T&K-keskuksen Cambridgeen vuonna 2025 tukemaan โฆSee details»
Orion Corporation - Crunchbase Company Profile
Orion Corporation is a globally operating Finnish company developing pharmaceuticals and diagnostic tests โ a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active โฆSee details»
Fermion is a subsidiary of Orion Corporation
Subsidiary of Orion Corporation and headquartered in Espoo, Finland. Together with Orion we are a fully integrated contract development and manufacturing organization (CDMO) and offer โฆSee details»
Orion - Overview, News & Similar companies | ZoomInfo.com
Orion contact info: Phone number: +358 104261 Website: www.orion.fi What does Orion do? Orion Diagnostica Oy, headquartered in Espoo, Finland, is a company that creates, โฆSee details»
Orion on suomalainen lääkeyhtiö โ โฆ
Finland fi en. France Germany Hungary India Ireland Italy Japan Kazakhstan ru kz. Latvia Lithuania Malaysia Netherlands nl fr. Norway Poland Singapore Slovenia Spain Sweden โฆSee details»
Orion CEO and Key Executive Team | Craft.co
Orion's President and CEO is Timo Lappalainen. Other executives include Jari Karlson, Chief Financial Officer, Senior Vice President, Animal Health; Olli Huotari, Senior Vice President, โฆSee details»
ORION CORPORATION STOCK EXCHANGE RELEASE
Olli Huotari, Senior Vice President responsible for Corporate Functions organization of the Orion Group and Secretary to the Board of Directors of Orion Corporation, and a member of the โฆSee details»
Orion is developing the Finnish life science industry in a unique ...
Jun 3, 2024 ORION CORPORATION PRESS RELEASE 03 June 2024 at 09.30 EEST Orion is participating in a project led by the University of Turku for which Business Finland recently โฆSee details»
CORRECTION: Change in Orion Group Executive Management โฆ
Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million โฆSee details»
Investors - orion.fi
Nov 27, 2024 Orion Corporation, Orionintie 1A, 02200 Espoo. PO Box 65, FI-02101 Espoo, Finland Phone +358 10 4261See details»
Muutoksia Orion-konsernin johtoryhmässä ja uusi โฆ
Jan 1, 2023 Orion on vahvassa kunnossa, mikä luo erinomaisen pohjan yhtiön tulevaisuuden rakentamiselleโ, toteaa Orionin toimitusjohtajana 1.11.2022 aloittava Liisa Hurme. Muutokset โฆSee details»
Orionโs near-term climate targets approved by the Science Based โฆ
Sep 30, 2024 Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR โฆSee details»
Orion is building a unique pharmaceutical research ecosystem in โฆ
Orion is launching a project to build a unique data and AI-based pharmaceutical research ecosystem in Finland in cooperation with other companies, research institutes and universities. โฆSee details»
Orion Weiss concludes his 'Arc' trilogy with music of joy, youth โฆ
1 day ago Pianist Orion Weiss has been working on a trilogy of piano recordings since 2014. The music on the first album, Arc I, is foreboding and fearful, while Arc II is about grief and โฆSee details»